Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies

NCT07681141 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Patients With Advanced Metastatic FAP-Positive Tumors

Interventions

DRUG: 177Lu-JH040182 with an activity of approximately 5.55-7.50 GBq

Sponsor

First Affiliated Hospital of Fujian Medical University